Lifeboat Foundation

A major medical organization has endorsed human genetic modification for the first time. THe panel suggested that trials be limited at the moment.

This single pill releases weeks worth of medication.

Mini-brains created in a lab are growing their own blood vessels.

Meet the man who bumped his head and woke up with a brand new talent…

World-first therapy has reversed one French boy’s blood disease.

The technique could be particularly useful for combating blood-related cancers and other disorders, as well as its anti-aging potential.

Cryopreservation is the process of freezing organs and tissues at very low temperatures in order to preserve them. While it sounds simple in theory, only a handful of cells and tissues have survived this method. This is because while science has successfully developed ways to cool organs to the very low temperatures required for preservation, thawing them out has proven far more difficult. As the specimen thaws, it forms ice crystals, which can damage the tissue and render organs unusable.

Right now, the process is only a viable option for small samples, such as sperm or embryos. Previous efforts using slow warming techniques have proven to be effective on samples of that size, but haven’t worked for larger tissue samples, like whole human organs. The inability to safely thaw the tissue has also precluded the theoretical concept of cryogenically preserving entire human bodies, with the intention of reanimating them later. The concept has roots in cryogenic technology, but is actually referred to as “cryonics”, and the scientific community generally considers it to be more science fiction than science fact — at least for the time being.

A recent study has made a significant breakthrough which may well begin closing that gap even more. Using a new technique, scientists were able to cryopreserve human and pig samples, then successfully rewarm it without causing any damage to the tissue.

Continue reading “Scientists Have Made a Huge Breakthrough In Cryogenics” »

Bioquark, a biotech company based in the United States, has been given the go-ahead to begin research on 20 brain-dead patients, in an attempt to stimulate and regrow neurons and, literally, bring the patients back from the dead.

The technique is new and untested so the study will likely be controversial. By implanting stem cells in the patient’s brain, in addition to treating the spinal cord with infusions of chemicals and nerve stimulation techniques (both of which have been shown to bring people out of comas), they hope to reboot the brain and jump-start neural activity.

The result could be people coming back to life.

Software we can upgrade. Genetics and biotech have made “LIFE” our new canvas.